Mitochondrial β-amyloid in Alzheimer's disease

Biochemical Society Transactions

Volumn 39, Issue 4, 2011, Pages 868-873

  Borger, Eva ^a   Aitken, Laura ^a   Muirhead, Kirsty E A ^a   Allen, Zoe E ^a   Ainge, James A ^a   Conway, Stuart J ^b   Gunn Moore, Frank J ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alzheimer's disease (AD); Amyloid binding alcohol dehydrogenase (ABAD); Cyclohexenyl amine naphthalene alcohol (CHANA); Cyclophilin D (CypD); Intracellular amyloid peptide (intracellular A ); Mitochondrial dysfunction

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; AMYLOID BETA PROTEIN; AMYLOID BINDING ALCOHOL DEHYDROGENASE; BINDING PROTEIN; CALCIUM ION; CYCLIN DEPENDENT KINASE 5; CYCLOPHILIN D; ENDOPHILIN; ENDOPLASMIC RETICULUM ASSOCIATED AMYLOID BINDING PROTEIN; LACTATE DEHYDROGENASE; MITOCHONDRIAL PHOSPHATE CARRIER; MITOCHONDRIAL PROTEIN; PEROXIREDOXIN 2; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; THIOREDOXIN 1; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

ALZHEIMER DISEASE; BINDING SITE; CELL DEATH; CELL LEVEL; CELL STRESS; CONFERENCE PAPER; CRYSTALLOGRAPHY; DELIRIUM; DRUG TARGETING; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPOGLYCEMIA; IMMUNOPRECIPITATION; ISCHEMIA; MITOCHONDRION; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; SHORT TERM MEMORY; SURFACE PLASMON RESONANCE;

3-HYDROXYACYL COA DEHYDROGENASES; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; DRUG EVALUATION, PRECLINICAL; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; PEPTIDYLPROLYL ISOMERASE;

ANIMALIA;

EID: 79960868236     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390868     Document Type: Conference Paper

References (57)

1. Foster, N.L., Chase, T.N., Fedio, P., Patronas, N.J., Brooks, R.A. and Di Chiro, G. (1983) Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology 33, 961-965 (Pubitemid 13030175)
2. Duara, R., Grady, C., Haxby, J., Sundaram, M., Cutler, N.R., Heston, L., Moore, A., Schlageter, N., Larson, S. and Rapoport, S.I. (1986) Positron emission tomography in Alzheimer's disease. Neurology 36, 879-887 (Pubitemid 16098229)
3. Beal, M.F. (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38, 357-366
4. Bowling, A.C. and Beal, M.F. (1995) Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56, 1151-1171
5. Parker, Jr, W.D., Mahr, N.J., Filley, C.M., Parks, J.K., Hughes, D., Young, D.A. and Cullum, C.M. (1994) Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44, 1086-1090 (Pubitemid 24188183)
6. Parker, Jr, W.D., Parks, J., Filley, C.M. and Kleinschmidt-DeMasters, B.K. (1994) Electron transport chain defects in Alzheimer's disease brain. Neurology 44, 1090-1096 (Pubitemid 24188184)
7. Sayre, L.M., Zelasko, D.A., Harris, P.L.R, Perry, G., Salomon, R.G. and Smith, M.A. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68, 2092-2097 (Pubitemid 27176147)
8. Richter, C., Park, J.W. and Ames, B.N. (1988) Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. U.S.A. 85, 6465-6467
9. Beal, M.F. (2005) Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 58, 495-505
10. Liu, J., Head, E., Gharib, A.M., Yuan, W., Ingersoll, R.T., Hagen, T.M., Cotman, C.W. and Ames, B.N. (2002) Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-α-lipoic acid. Proc. Natl. Acad. Sci. U.S.A. 99, 2356-2361
11. Cottrell, D.A., Blakely, E.L., Johnson, M.A., Ince, P.G. and Turnbull, D.M. (2001) Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD. Neurology 57, 260-264 (Pubitemid 32667359)
12. Bubber, P., Haroutunian, V., Fisch, G., Blass, J.P. and Gibson, G.E. (2005) Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann. Neurol. 57, 695-703
13. Gibson, G.E., Park, L.C., Zhang, H., Sorbi, S. and Calingasan, N.Y. (1999) Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits. Ann. N.Y. Acad. Sci. 893, 79-94
14. Lustbader, J.W., Cirilli, M., Lin, C., Xu, H.W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M. et al. (2004) ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease. Science 304, 448-452 (Pubitemid 38495942)
15. Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J.W., Wei Xu, H., Stern, D., McKhann, G. and Yan, S.D. (2005) Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 19, 2040-2041
16. Yao, J., Irwin, R.W., Zhao, L., Nilsen, J., Hamilton, R.T. and Brinton, R.D. (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 106, 14670-14675
17. Anandatheerthavarada, H.K., Biswas, G., Robin, M.A. and Avadhani, N.G. (2003) Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161, 41-54 (Pubitemid 36459078)
18. Devi, L., Prabhu, B.M., Galati, D.F., Avadhani, N.G. and Anandatheerthavarada, H.K. (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci. 26, 9057-9068 (Pubitemid 44319397)
19. Hansson Petersen, C.A., Alikhani, N., Behbahani, H., Wiehager, B., Pavlov, P.F., Alafuzoff, I., Leinonen, V., Ito, A., Winblad, B., Glaser, E. and Ankarcrona, M. (2008) The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc. Natl. Acad. Sci. U.S.A. 105, 13145-13150
20. Casley, C.S., Land, J.M., Sharpe, M.A., Clark, J.B., Duchen, M.R. and Canevari, L. (2002) β-Amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol. Dis. 10, 258-267
21. Chen, J.X. and Yan, S.D. (2007) Amyloid-β-induced mitochondrial dysfunction. J. Alzheimer's Dis. 12, 177-184
22. Canevari, L., Clark, J.B. and Bates, T.E. (1999) β-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett. 457, 131-134 (Pubitemid 29387424)
23. Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A.A., McKhann, G.M., Yan, Y., Wang, C., Zhang, H., Molkentin, J.D. et al. (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat. Med. 14, 1097-1105
24. Yan, S.D., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T. et al. (1997) An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389, 689-695 (Pubitemid 27458947)
25. Du, H., Guo, L., Zhang, W., Rydzewska, M. and Yan, S. (2011) Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model. Neurobiol. Aging 32, 398-406
26. Connern, C.P. and Halestrap, A.P. (1994) Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem. J. 302, 321-324 (Pubitemid 24280079)
27. Crompton, M., Virji, S. and Ward, J.M. (1998) Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur. J. Biochem. 258, 729-735
28. Oppermann, U.C., Salim, S., Tjernberg, L.O., Terenius, L. and Jornvall, H. (1999) Binding of amyloid β-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease. FEBS Lett. 451, 238-242 (Pubitemid 29243784)
29. Muirhead, K.E.A., Borger, E., Aitken, L., Conway, S.J. and Gunn-Moore, F.J. (2010) The consequences of mitochondrial amyloid β-peptide in Alzheimer's disease. Biochem. J. 426, 255-270
30. Tieu, K., Perier, C., Vila, M., Caspersen, C., Zhang, H.-P., Teismann, P., Jackson-Lewis, V., Stern, D.M., Yan, S.D. and Przedborski, S. (2004) L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease. Ann. Neurol. 56, 51-60
31. Yan, S.D., Zhu, Y., Stern, E.D., Hwang, Y.C., Hori, O., Ogawa, S., Frosch, M.P., Connolly, Jr, E.S., McTaggert, R., Pinsky, D.J. et al. (2000) Amyloid β-peptide-binding alcohol dehydrogenase is a component of the cellular response to nutritional stress. J. Biol. Chem. 275, 27100-27109
32. Takuma, K., Yao, J., Huang, J., Xu, H., Chen, X., Luddy, J., Trillat, A.C., Stern, D.M., Arancio, O. and Yan, S.S. (2005) ABAD enhances Aβ-induced cell stress via mitochondrial dysfunction. FASEB J. 19, 597-598 (Pubitemid 40471256)
33. Kissinger, C.R., Rejto, P.A., Pelletier, L.A., Thomson, J.A., Showalter, R.E., Abreo, M.A., Agree, C.S., Margosiak, S., Meng, J.J., Aust, R.M. et al. (2004) Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics. J. Mol. Biol. 342, 943-952
34. Yan, S.D., Shi, Y., Zhu, A., Fu, J., Zhu, H., Zhu, Y., Gibson, L., Stern, E., Collison, K., Al-Mohanna, F. et al. (1999) Role of ERAB/L-3-hydroxyacyl- coenzyme a dehydrogenase type II activity in Aβ-induced cytotoxicity. J. Biol. Chem. 274, 2145-2156
35. Ren, Y., Xu, H.W., Davey, F., Taylor, M., Aiton, J., Coote, P., Fang, F., Yao, J., Chen, D., Chen, J.X. et al. (2008) Endophilin I expression is increased in the brains of Alzheimer disease patients. J. Biol. Chem. 283, 5685-5691
36. Yao, J., Taylor, M., Davey, F., Ren, Y., Aiton, J., Coote, P., Fang, F., Chen, J.X., Yan, S.D. and Gunn-Moore, F.J. (2007) Interaction of amyloid binding alcohol dehydrogenase/Aβ mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model. Mol. Cell. Neurosci. 35, 377-382
37. Ramjaun, A.R., Angers, A., Legendre-Guillemin, V., Tong, X.-K. and McPherson, P.S. (2001) Endophilin regulates JNK activation through its interaction with the germinal center kinase-like kinase. J. Biol. Chem. 276, 28913-28919
38. Colombo, A., Bastone, A., Ploia, C., Sclip, A., Salmona, M., Forloni, G. and Borsello, T. (2009) JNK regulates APP cleavage and degradation in a model of Alzheimer's disease. Neurobiol. Dis. 33, 518-525
39. Tamagno, E., Parola, M., Bardini, P., Piccini, A., Borghi, R., Guglielmotto, M., Santoro, G., Davit, A., Danni, O., Smith, M.A. et al. (2005) β-Site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 92, 628-636 (Pubitemid 40189465)
40. Lagalwar, S., Guillozet-Bongaarts, A.L., Berry, R.W. and Binder, L.I. (2006) Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 65, 455-464
41. Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I. and Rydel, R.E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389
42. Kuwako, K.-I., Nishimura, I., Uetsuki, T., Saido, T.C. and Yoshikawa, K. (2002) Activation of calpain in cultured neurons overexpressing Alzheimer amyloid precursor protein. Mol. Brain Res. 107, 166-175
43. Saito, K., Elce, J.S., Hamos, J.E. and Nixon, R.A. (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 90, 2628-2632
44. Liang, B., Duan, B.-Y., Zhou, X.-P., Gong, J.-X. and Luo, Z.-G. (2010) Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J. Biol. Chem. 285, 27737-27744
45. Qu, D., Rashidian, J., Mount, M.P., Aleyasin, H., Parsanejad, M., Lira, A., Haque, E., Zhang, Y., Callaghan, S., Daigle, M. et al. (2007) Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 55, 37-52 (Pubitemid 46990825)
46. Cole, A.R., Noble, W., van Aalten, L., Plattner, F., Meimaridou, R., Hogan, D., Taylor, M., LaFrancois, J., Gunn-Moore, F., Verkhratsky, A. et al. (2007) Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. J. Neurochem. 103, 1132-1144 (Pubitemid 47568734)
47. Cruz, J.C., Kim, D., Moy, L.Y., Dobbin, M.M., Sun, X., Bronson, R.T. and Tsai, L.-H. (2006) p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid β in vivo. J. Neurosci. 26, 10536-10541 (Pubitemid 44564604)
48. Smith, P.D., Crocker, S.J., Jackson-Lewis, V., Jordan-Sciutto, K.L., Hayley, S., Mount, M.P., O'Hare, M.J., Callaghan, S., Slack, R.S., Przedborski, S. et al. (2003) Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 13650-13655
49. Vega, I.E., Traverso, E.E., Ferrer-Acosta, Y., Matos, E., Colon, M., Gonzalez, J., Dickson, D., Hutton, M., Lewis, J. and Yen, S.H. (2008) A novel calcium-binding protein is associated with tau proteins in tauopathy. J. Neurochem. 106, 96-106 (Pubitemid 351840193)
50. Blass, J.P. (2000) The mitochondrial spiral: an adequate cause of dementia in the Alzheimer's syndrome. Ann. N.Y. Acad. Sci. 924, 170-183
51. Blass, J.P. (2001) Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia? J. Neurosci. Res. 66, 851-856
52. Lin, M.T. and Beal, M.F. (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795 (Pubitemid 44622683)
53. Milton, N.G., Mayor, N.P. and Rawlinson, J. (2001) Identification of amyloid-β binding sites using an antisense peptide approach. NeuroReport 12, 2561-2566 (Pubitemid 32682222)
54. Yang, X., Yang, Y., Wu, J. and Zhu, J. (2007) Stable expression of a novel fusion peptide of thioredoxin-1 and ABAD-inhibiting peptide protects PC12 cells from intracellular amyloid-β. J. Mol. Neurosci. 33, 180-188
55. Yao, J., Du, H., Yan, S., Fang, F., Wang, C., Lue, L.-F., Guo, L., Chen, D., Stern, D., Gunn-Moore, F.J. et al. (2011) Inhibition of ABAD-Aβ interaction reduces Aβ accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease. J. Neurosci. 31, 2313-2320
56. Froemming, M.K. and Sames, D. (2007) Harnessing functional plasticity of enzymes: a fluorogenic probe for imaging 17β-HSD10 dehydrogenase, an enzyme involved in Alzheimer's and Parkinson's diseases. J. Am. Chem. Soc. 129, 14518-14522
57. Muirhead, K.E.A., Froemming, M., Li, X., Musilek, K., Conway, S.J., Sames, D. and Gunn-Moore, F.J. (2010) (-)-CHANA, a fluorogenic probe for detecting amyloid binding alcohol dehydrogenase HSD10 activity in living cells. ACS Chem. Biol. 5, 1105-1114